Streetbeat News

Earnings

RBT

Rubicon Technologies reported lower than expected Q3 revenue results, leading to a drop in its share price. Additionally, Canaccord Genuity downgraded the stock from Buy to Hold and reduced its price target from $3 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:51 pm

FLL

Full House Resorts reported better-than-expected Q3 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:50 pm

BIIB

Biogen Inc (NASDAQ:BIIB) reported better-than-expected Q3 earnings with sales of $2.53 billion, beating the consensus of $2.39 billion. However, the company revised its FY23 revenues to decline in a low-single-digit percentage versus FY22. Following the earnings announcement, Wells Fargo and RBC Capital increased their price targets on Biogen, while Wedbush cut its price target.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 6:49 pm

ARM

Analysts from BMO Capital, KeyBanc Capital Markets, Mizuho Securities, and Goldman Sachs remain bullish on Arm Holdings Plc (NASDAQ:ARM) despite concerns over royalty rates. The analysts highlighted the company's strong Q2 results, robust licensing growth, and its position as a global leader in semiconductor IP licensing. However, they noted a lower outlook for mobile royalties due to smartphone weakness. The analysts have set price targets ranging from $60 to $65.

Portfolio Pulse from Anusuya Lahiri

November 09, 2023 | 6:49 pm

VNDA

Vanda Pharmaceuticals reported worse-than-expected Q3 revenue results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:49 pm

MRMD

MariMed Inc. (MRMD) reported Q3 earnings with revenue of $38.8 million, a YoY increase of over 14%. The company's gross profit totaled $16.8 million, up from $16.1 million in the prior year’s period. However, net loss was $4.2 million, compared to the net income of $2.7 million in the prior year’s period. The company's guidance for full-year 2023 includes revenue of $148 million to $150 million and a gross margin of approximately 45%. MariMed’s shares traded 1.5625% lower at $0.315 per share at the time of writing on Thursday morning.

Portfolio Pulse from Jelena Martinovic

November 09, 2023 | 6:49 pm

BIRD

Allbirds reported a YoY decrease in Q3 EPS results and worse-than-expected revenue results. The company also issued Q4 revenue guidance below estimates. Wedbush and Telsey Advisory Group lowered their price targets on the stock.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:43 pm

RAMP

LiveRamp Holdings, Inc. (NYSE:RAMP) reported better-than-expected Q2 results and issued strong Q3 guidance. The company's Q2 earnings were 43 cents per share, beating market estimates of 24 cents per share. Q2 sales were $160 million, exceeding expectations of $152.26 million. LiveRamp anticipates Q3 revenue of $165 million, compared to estimates of $163.11 million. Following the earnings announcement, analysts from Morgan Stanley, Susquehanna, and Benchmark increased their price targets on LiveRamp.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 6:41 pm

GDRX

GoodRx Holdings Inc's Q3 sales decreased 4% Y/Y to $180.0 million, primarily due to a $10.0 million contract termination payment to a client. Adjusted revenue increased 1% to $190.0 million, driven by prescription transaction revenue growth. The company exited Q3 with over 7 million consumers of prescription-related offerings. GoodRx expects FY23 adjusted revenue of $752 million-$758 million. GDRX shares are down 20.90% at $4.33.

Portfolio Pulse from Vandana Singh

November 09, 2023 | 6:35 pm

AFRM

Affirm Holdings, Inc. (NASDAQ:AFRM) reported better-than-expected Q1 results, with losses of 57 cents per share and sales of $496.55 million, beating analyst consensus estimates. The company also provided Q2 revenue guidance of $495 million to $520 million. Following the earnings announcement, several analysts increased their price targets on Affirm. The company's shares jumped 18.8% to trade at $25.85 on Thursday.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 6:33 pm